Department of Ophthalmology, Madigan Army Medical Center, Tacoma, WA.
Department of Ophthalmology, Walter Reed National Military Medical Center.
J Glaucoma. 2023 Jul 1;32(7):e71-e79. doi: 10.1097/IJG.0000000000002208. Epub 2023 Mar 13.
Ab externo transconjunctival placement of the Xen-45 gel stent offers a faster surgical approach and more rapid visual recovery with similar pressure-lowering and complication rates when compared with implantation by the ab interno approach.
Compare outcomes of closed conjunctival Xen-45 implantation techniques: ab interno versus ab externo transconjunctival.
Single-center, retrospective study of 70 patients undergoing Xen-45 implantation between 2017 and 2020. Group 1 (n=29) had ab interno placement, Group 2 (n=41) had transconjunctival ab externo placement. Primary outcome measures were intraocular pressure (IOP) and medication use. Secondary measures were bleb revision rates, surgical time, time to return to baseline visual acuity, and complication rates.
Group 1, preoperative IOP was 22.8±7.5 mmHg on 3.8±0.9 IOP-lowering medications and the postoperative IOP at last follow-up was 11.6±2.8 mmHg on 1.6±1.3 medications. Group 2, preoperative IOP was 25.6 mmHg±7.8 mmHg on 3.7±1.1 medications and the postoperative IOP at last follow-up was 12.4±3.6 mmHg on 1.5±1.3 medications. There was no difference in postoperative IOP or medications between the 2 groups ( P <0.05). The average surgical time for Group 2 was 25±6.5 minutes to 37±7.3 minutes for Group 1 ( P <0.001). Group 2 showed 88% of patients returning to baseline visual acuity at week 2 compared with 66% in Group 1 ( P <0.05). Bleb revision rates, failure rates, and complication rates were comparable between both groups ( P >0.05).
IOP, medication use, complications, bleb revision rates, and failure rates were similar between ab interno and ab externo transconjunctival approaches. The ab externo group had faster surgical times and postoperative visual recovery despite higher number of patients with previous glaucoma procedures.
与经内路植入相比,外路经结膜 Xen-45 凝胶支架的巩膜外安置提供了更快的手术途径和更快的视力恢复,同时具有相似的降压和并发症发生率。
比较经结膜闭合 Xen-45 植入技术的结果:经内路与经外路。
对 2017 年至 2020 年间接受 Xen-45 植入的 70 例患者进行单中心回顾性研究。第 1 组(n=29)采用经内路放置,第 2 组(n=41)采用外路经结膜巩膜外放置。主要观察指标为眼内压(IOP)和药物使用。次要观察指标为滤泡修复率、手术时间、恢复至基线视力的时间和并发症发生率。
第 1 组术前 IOP 为 22.8±7.5mmHg,使用 3.8±0.9 种降压药物,末次随访时的术后 IOP 为 11.6±2.8mmHg,使用 1.6±1.3 种药物。第 2 组术前 IOP 为 25.6mmHg±7.8mmHg,使用 3.7±1.1 种药物,末次随访时的术后 IOP 为 12.4±3.6mmHg,使用 1.5±1.3 种药物。两组术后 IOP 或药物使用无差异(P<0.05)。第 2 组的平均手术时间为 25±6.5 分钟,而第 1 组为 37±7.3 分钟(P<0.001)。第 2 组有 88%的患者在第 2 周恢复至基线视力,而第 1 组为 66%(P<0.05)。两组的滤泡修复率、失败率和并发症发生率相似(P>0.05)。
经内路和外路经结膜途径的 IOP、药物使用、并发症、滤泡修复率和失败率相似。尽管第 2 组中先前有青光眼手术的患者数量较多,但外路组的手术时间更快,术后视力恢复更快。